According to people involved in the regulatory process, the United States will approve the use of the Bioentech and Pfizer coronavirus vaccines in children aged 12-15 in the coming days.
Pharmaceutical companies applied for approval Start vaccinating adolescents After testing last month, it was suggested that inoculations were 100% effective in preventing symptomatic disease within the age range.
Two people close to the process said they expected the Food and Drug Administration to give it its green light next week, a move that could help bring America closer to “pastoral resistance” and play a key role in reopening full-time schools in the fall.
The FDA and Pfizer declined to comment.
Bioentech / Pfizer vaccine that was Approved According to data from the U.S. Centers for Disease Control and Prevention, 131 meters have been operated on people aged 1m or older. It has helped vaccinate more than 50 percent of its adult population in the United States with a single dose, making it the world’s largest Covid-19 inclusion campaign.
Vaccination campaigns have helped reduce lawsuits and deaths in the United States in recent weeks. According to The latest statistics Compiled by the Financial Times, the country reports about 50,000 cases and 70,000 deaths a day – more than the average rate in October last year.
Scientists say so To reach the immunity of the animal – There are enough people with antibodies where the virus can no longer spread – but the US people will need to be vaccinated in more than three-quarters of its population. It is difficult not to vaccinate children as well
In March, Pfeiffer reported the results of a 3-step clinical trial among 12-15 year olds, which showed Good results Compared to 16-25 year olds. Of the 2,260 adolescents who took part in the test, 18 were infected with Covid-19 – all in the placebo group.
The FDA approves all drugs in the United States, avoiding the need for lengthy consultations with outside experts, and does not need to issue new approvals for the Pfizer vaccine to be used in the under-1s.
However, the CDC, which issues public health guidelines, will consult with an external panel of scientists before making its own recommendations. According to a person aware of the plans, the panel was expected to hold a meeting next week with 12- to 15-year-old Fizer Jab about vaccination.
Anthony Fawcett, head of the US National Institute for Allergy and Infectious Diseases, said earlier that he hoped secondary school-age children would be vaccinated in the autumn and next year.